<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 01 Mar 2021 16:19:51 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>预约接种火爆，新冠疫苗为大湾区疫后重建带来新希望丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/_e0VFMHr1H9cUZXeaNPIpw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIum12oDGAH2oTf2txmMdYoSjGyIA7oUruSib9MYepgOLNrpib3RZdf9b4mosupdlfeh1wzbmODAmibtw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>“病毒无国界，疫苗是全人类的财富”]]></content:encoded><pubDate>Mon, 01 Mar 2021 14:08:12 +0800</pubDate></item><item><title>CAR-T背后的英雄，慢病毒载体生产工艺剖析 | 医麦课堂</title><link>https://mp.weixin.qq.com/s/OuEwesL4MVBx_vLtNvY3LA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIum12oDGAH2oTf2txmMdYoSIrCCePIPRoVExgFKeXRNrbTYu8tRN1ib7dU6nttru41QlaqwMZ6aMiaQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>降低CAR-T成本和污染风险]]></content:encoded><pubDate>Mon, 01 Mar 2021 14:08:12 +0800</pubDate></item><item><title>明济生物Claudin 18.2单抗获得临床批件丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/79-76yZmrvYXH8BKvRVgQg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIum12oDGAH2oTf2txmMdYoSloB3JDDbGWHkAZscQS9GX448Kia7yuBMbKN1IK600UYHLicB1KTm15ug/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ADCC增强型抗体]]></content:encoded><pubDate>Mon, 01 Mar 2021 14:08:12 +0800</pubDate></item><item><title>药融资丨致力于开发具有国际竞争力的偶联药物，宜联生物A轮融资数亿元</title><link>https://mp.weixin.qq.com/s/JuRbdUNCJZa-WkZ3sG3FwA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIum12oDGAH2oTf2txmMdYoSbxeLJC1t0bx8WjutlYkeH7MQcNVXHoLtdjhtvdnouGQMCBEXc7GYmg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>两个月内相继完成总计3.5亿元人民币的A轮融资。]]></content:encoded><pubDate>Mon, 01 Mar 2021 14:08:12 +0800</pubDate></item><item><title>CAR-T前浪Juno首款产品上市之路，对国内产品开发和审批有何启发？丨医麦新观察</title><link>https://mp.weixin.qq.com/s/2nErRwKRPKBssSKPWxVBrg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsadULslOicUx7k0B73puR8SUS4WNT85K32cUibQlL0E6b0vLWmqk3esKq6mqvcBq0icJ0U40ATVseRQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>全球第四款CAR-T疗法近日获得了FDA的上市批准]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:17:25 +0800</pubDate></item><item><title>北恒生物联合浙江大学医学院附属第一医院发表首篇基于CRISPR/Cas9基因编辑双靶点通用型CAR-T治疗B急淋的临床研究成果</title><link>https://mp.weixin.qq.com/s/KJfA2ze8S5lvx5m_PvR26A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsadULslOicUx7k0B73puR8SkPI35EwKJ3rTdrCQW26cl5W9p0rArk6hOX0Xq8dc2kLIIeib4a0UQqw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>5例（83%）患者获得CR/CRi，且均获得MRD-。]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:17:25 +0800</pubDate></item><item><title>第14个国际罕见病日丨Rare is many. Rare is strong. Rare is proud.</title><link>https://mp.weixin.qq.com/s/ahrzVLJYh9A92IUP9TO3wg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIugskouXoAuOc2wOYGC2w3C2CpsOWnDiciaicPia8THhlHuLiabbDcffPSFbbrLjibEl1wF7dtstbuF5Vdg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>基因治疗给治愈罕见病带来希望]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:17:25 +0800</pubDate></item><item><title>巨头纷纷下场，开启细胞与基因治疗时代丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/7DkJtuWXS8Rq1f2FKYbP_A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsadULslOicUx7k0B73puR8SDN5ict9lS0Mia1bvKZBz6yiaibbRq8xp0q6xRic2jHLqy1nRGYmUEPmEo9Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>持续火热的细胞与基因治疗]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:17:25 +0800</pubDate></item><item><title>3月即将上市，首款递交上市申请的 BCMA CAR-T疗法发布关键Ⅱ期研究数据丨医麦新观察</title><link>https://mp.weixin.qq.com/s/dyQmEjc8pEfniMTXiGczgg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIugskouXoAuOc2wOYGC2w3CXRPaXGrIEfH3hHYwqKDVKHe5vedJFGWkhcxIOjffxGtxFdS1BzetWw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>PDUFA目标日期：2021年3月27日]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:31:43 +0800</pubDate></item><item><title>药融资丨诺华、吉利德、BMS、安斯泰来看好，这家公司什么来头</title><link>https://mp.weixin.qq.com/s/qojBasm94_CSmX37IyBxIQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIugskouXoAuOc2wOYGC2w3CvINO1xbeHzrKS4xIgMI3LN2cNOU9RDjSIDOGDeG3uL35vGmrjGDxqw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>oRNA具有更多优势]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:31:43 +0800</pubDate></item><item><title>慢病毒基因疗法成功治疗法布里病患者，基因治疗给世界带来更多希望丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/47qKWdYOUQp_TqQKl3vmjw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIugskouXoAuOc2wOYGC2w3COxCrLJh5HwlGWofvLicsmXmmDmyR7WvmFdceO1lmWMV4PicydyQFGuow/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>加拿大首个慢病毒基因疗法临床试验]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:31:43 +0800</pubDate></item><item><title>中国基因治疗里程碑合作，病毒载体CDMO派真生物携手颇尔开发基因治疗生产技术丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Z-OCAveRPR4Oq3nX3B7EFQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIslmLz1uSdwOewdz48QBhXTcjSsz3NCJUDB5d3ZIISSLibGlUe48FQC0icWKAsUCLtXwtOic0HfSNiaqA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>重磅！强强战略联合！]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:37:58 +0800</pubDate></item><item><title>药融资丨君赛生物完成近亿元人民币A轮融资，加快TIL细胞新药管线推进</title><link>https://mp.weixin.qq.com/s/7ivitxQUVg_wIV0qeJIlyA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIslmLz1uSdwOewdz48QBhXTOh1wSXuAlKDSqvicGrOyDUQE0J34fN2B9YVqea6o8rliauGiaMfwnKjbA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>加速推进TIL细胞新药的开发]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:37:58 +0800</pubDate></item><item><title>韩国首张CAR-T临床批件正式下批，下调PD1和TIGIT以克服肿瘤微环境丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/GqZ8xtpk7AGsGXcs7nBNoQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIslmLz1uSdwOewdz48QBhXTU1HLN5MjljN3kPciaDgVtzhc6s6XNsfMhFicPQeib6PnZZ1r0tdicuzSNg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>下调PD1和TIGIT的CAR-T进入临床开发阶段]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:37:58 +0800</pubDate></item><item><title>解读丨浅析CAR-T在中国的发展及监管状况</title><link>https://mp.weixin.qq.com/s/ThRq1G8gwsErHZdt6Dau1Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfMfuqDwWUn8Dia3jmLVbZsiapCJpRKibGKDSDjdLIS7Q7via8Oe2hMQ5RQfg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>细胞和基因治疗产品监管政策趋势与合规探讨]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>博腾生物GMP悬浮无血清慢病毒生产平台，助力基因与细胞治疗丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/ClLpZcJ1Zog4GzlV212vQw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfM2vduCl259PDOXTQCEWFOnrCBFb7OZtIJSaXIOxJSwZDcsbVlEy6t6Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>博腾生物已经成功建立了悬浮无血清慢病毒工艺开发和GMP生产平台，具有细胞培养上清病毒载体滴度高、无动物源性成分、工艺操作简单化、纯化工艺感染滴度回收率高、生产成本降低以及易于放大等优势。]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>静脉给药的溶瘤病毒联合CAR-T疗法有望治愈实体瘤丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/9mDINOvxMUph_gnSlTKlHA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfMC8NOP1rqNq6pBLduvYY3hvQl8tV26D71wOT2s53mTJVWbOWt0NMcFw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>联合策略的又一力证]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>华龛生物第二款药辅资质获得CDE审批丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/-acWWhTYJhmrH33iu27TQg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfMQUovcLMSKr9CmVuvH455DnXFs7PCuh3dickgYgXYOpsRialaHHKEeS8w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第二款获得CDE药用辅料资质的产品]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>mRNA工程化CAR-T疗法启动2期临床试验，灵活的创新平台适用于各类细胞改造丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Pom-eU96EOMMndmuXKHKvA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfM1N3Con4PibJpAI6icVTax9J8oicibNovKTA78mH7uhJaGEQia5qkr08wCaA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>短暂而非永久的表达CAR分子，提高安全性]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>专访卡替医疗CSO高斌教授：与癌症堡垒展开T细胞立体式作战</title><link>https://mp.weixin.qq.com/s/DQdEEss79vqF0seeR-bZlA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItibdqytdbEzGfEdG0r87ISiciaWGibSicbAGCb6NOMicGZEUwuglGKHjX8CoNao5mDUZAdnkWDIFd1dRDg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>TIL疗法或许是解决肿瘤异质性难题的好办法。]]></content:encoded><pubDate>Tue, 23 Feb 2021 19:23:39 +0800</pubDate></item></channel></rss>